Cargando…
O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
Programmed-death ligand 1 (PD-L1) and its receptor programmed cell death 1 (PD-1) mediate T cell–dependent immunity against tumors. The abundance of cell surface PD-L1 is a key determinant of the efficacy of immune checkpoint blockade therapy targeting PD-L1. However, the regulation of cell surface...
Autores principales: | Zhu, Qiang, Wang, Hongxing, Chai, Siyuan, Xu, Liang, Lin, Bingyi, Yi, Wen, Wu, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068856/ https://www.ncbi.nlm.nih.gov/pubmed/36943877 http://dx.doi.org/10.1073/pnas.2216796120 |
Ejemplares similares
-
O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling
por: Wu, Liming, et al.
Publicado: (2022) -
Mass Spectrometry for O-GlcNAcylation
por: Yin, Ruoting, et al.
Publicado: (2021) -
The role of O-GlcNAcylation in development
por: Czajewski, Ignacy, et al.
Publicado: (2023) -
Chemistry-Assisted Proteomic Profiling of O-GlcNAcylation
por: Zhu, Qiang, et al.
Publicado: (2021) -
The Role of O-GlcNAcylation in Immune Cell Activation
por: Qiang, Amy, et al.
Publicado: (2021)